These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10667895)

  • 1. Psychosocial impact of type-specific herpes simplex serological testing on asymptomatic sexual health clinic attendees.
    Smith A; Denham I; Keogh L; Jacobs D; McHarg V; Marceglia A; Wood V
    Int J STD AIDS; 2000 Jan; 11(1):15-20. PubMed ID: 10667895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review.
    Ross K; Johnston C; Wald A
    Sex Transm Infect; 2011 Dec; 87(7):594-600. PubMed ID: 21903980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2.
    Miyai T; Turner KR; Kent CK; Klausner J
    Sex Transm Dis; 2004 Sep; 31(9):517-21. PubMed ID: 15480111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.
    Hallfors DD; Cho H; Mbai II; Millimo BW; Atieno C; Okumu D; Luseno WK; Hartman S; Halpern CT; Hobbs MM
    Sex Transm Infect; 2015 Sep; 91(6):395-400. PubMed ID: 26139208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.
    Rosenthal SL; Zimet GD; Leichliter JS; Stanberry LR; Fife KH; Tu W; Bernstein DI
    Sex Transm Infect; 2006 Apr; 82(2):154-7; discussion 157-8. PubMed ID: 16581745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 serological testing at a community court: predictors of test acceptance and seropositivity among female defendants.
    Roth AM; Van Der Pol B; Fortenberry JD; Reece M; Dodge B; Certo D; Zimet GD
    Int J STD AIDS; 2013 Mar; 24(3):169-74. PubMed ID: 23467289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low acceptance of HSV-2 testing among high-risk women.
    Roth AM; Dodge BM; Van Der Pol B; Reece M; Zimet GD
    Int J STD AIDS; 2011 Jun; 22(6):329-31. PubMed ID: 21680668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review.
    Bastien S; Mason-Jones AJ; De Koker P; Mmbaga EJ; Ross DA; Mathews C
    Int J STD AIDS; 2012 Nov; 23(11):761-6. PubMed ID: 23155093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychological consequences in patient undergoing a POCKit HSV-2 test.
    Wilkinson D; Barton S; Chard S; Meadows J
    Int J STD AIDS; 2000 Aug; 11(8):551-2. PubMed ID: 10990342
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for the selective use of herpes simplex virus type 2 serological tests.
    Guerry SL; Bauer HM; Klausner JD; Branagan B; Kerndt PR; Allen BG; Bolan G
    Clin Infect Dis; 2005 Jan; 40(1):38-45. PubMed ID: 15614690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic.
    Meyer JL; Crosby RA; Whittington WL; Carrell D; Ashley-Morrow R; Meier AS; Harrington RD; DiClemente R; Wald A
    Sex Transm Infect; 2005 Aug; 81(4):309-15. PubMed ID: 16061537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes.
    Nieuwenhuis RF; van Doornum GJ; Mulder PG; Neumann HA; van der Meijden WI
    Acta Derm Venereol; 2006; 86(2):129-34. PubMed ID: 16648915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective identification of sexual risk behavior among blood donors in Croatia: is it reality?
    Miskulin M; Puntaric D; Bozikov J; Miskulin I; Ruzman N
    Clin Lab; 2012; 58(1-2):19-25. PubMed ID: 22372342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV-2 serologic testing in an HMO population: uptake and psychosocial sequelae.
    Richards J; Scholes D; Caka S; Drolette L; Magaret AM; Yarbro P; Lafferty W; Crosby R; Diclemente R; Wald A
    Sex Transm Dis; 2007 Sep; 34(9):718-25. PubMed ID: 17471113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do protective behaviors follow the experience of testing positive for herpes simplex type 2?
    Crosby RA; Head S; DiClemente RJ; Meyerson B; Troutman A
    Sex Transm Dis; 2008 Sep; 35(9):787-90. PubMed ID: 18607318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
    Ross SE; Carter B; Lambert S
    Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of herpes simplex virus type 2 among STD clinic attenders in Delhi, India.
    Kaur R; Mittal N; Bhalla P; Reddy BN; Baveja UK
    J Commun Dis; 2006 Dec; 38(4):339-43. PubMed ID: 17913210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parents' reactions to testing for herpes simplex virus type 2 as a biomarker of sexual activity in Botswana junior secondary school students.
    Cham HJ; Lasswell SM; Miller KS
    Sex Health; 2016 Apr; 13(2):148-54. PubMed ID: 26886026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
    Wald A; Ashley-Morrow R
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing.
    Lafferty WE
    Herpes; 2002 Jul; 9(2):51-5. PubMed ID: 12106513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.